Science s COVID-19 reporting is supported by the Heising-Simons Foundation
For people not yet vaccinated against COVID-19 or still nervous about venturing into crowds, the sales pitch may be alluring: Drool into a tube to provide your DNA and mail it off to see how likely you are to be among the 10% to 15% of people who will end up in the hospital or die from a SARS-CoV-2 infection. That s the promise of a $175 test an Australian company launched last week in the United States. It combines genetic data with someone s age, sex, and preexisting medical conditions to predict their risk of becoming extremely ill from COVID-19.
The firm developed its test using data on thousands of COVID-19 patients in the United Kingdom. It may be a forerunner of similar risk tests: An academic team has recently detailed a simpler genetic test to help determine how aggressively some people infected with SARS-CoV-2 should be treated.
Yet several genetics experts warn that how a person s genes influenc
Infinity BiologiX, Genetic Technologies and Vault Heath launch new test to assess severity of COVID-19 in individuals streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
12 Health Care Stocks Moving In Tuesday s After-Market Session
Gainers
Pieris Pharmaceuticals (NASDAQ:PIRS) shares increased by 9.04% to $4.1 during Tuesday’s after-market session. Trading volume for this security closed at 10.1 million, accounting for 1726.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $239.0 million.
Selecta Biosciences (NASDAQ:SELB) shares moved upwards by 8.12% to $3.86. Today’s trading volume for this security ended up closing at 130.4K shares, which is 11.74 percent of its average volume over the last 100 days. The company’s market cap stands at $436.9 million.
Avinger (NASDAQ:AVGR) shares moved upwards by 4.99% to $1.02. Today’s trading volume for this security ended up closing at 82.6K shares, which is 1.78 percent of its average volume over the last 100 days. The company’s market cap stands at $97.2 million.
Drug repurposing company Island Pharmaceuticals was started in 2017 after its founders decided there had to be a better way to treat mosquito-born viruses.
Genetic Technologies (GENE) appoints Mike Tonroe as CFO streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.